Discover

PEPG
PepGen Inc.
2.85
2 x 2.11
2 x 3.67
bid
ask
-
0.12
4.04%
2 @ 07:30 PM
2.90 +0.05 (1.75%)
Ytd-56.22%
1y39.02%
2.83
day range
2.98
1.35
52 week range
7.17
Open2.97Prev Close2.97Low2.83High2.98Mkt Cap197.13M
Vol580.50KAvg Vol942.73KEPS-1.00P/EN/AForward P/E-1.45
Beta1.76Short Ratio5.75Inst. Own96.36%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-1150-d Avg2.65200-d Avg3.551yr Est15.40

PEPG News

PepGen, Inc. $PEPG Shares Bought by Squarepoint Ops LLC
defenseworld.net
PepGen, Inc. $PEPG Shares Bought by Squarepoint Ops LLC

Squarepoint Ops LLC raised its holdings in PepGen, Inc. (NASDAQ: PEPG) by 260.9% during the undefine

12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers Alaunos Therapeutics (NASDAQ:TCRT) shares moved upwards by 30.0% to $2.08 during Thursday&#

benzinga.com
HC Wainwright & Co. Reiterates Buy on PepGen, Maintains $20 Price Target

HC Wainwright & Co. analyst Ananda Ghosh reiterates PepGen (NASDAQ:PEPG) with a Buy and maint

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers InnovAge Holding (NASDAQ:INNV) shares increased by 10.8% to $11.65 during Tuesday's aft

ADAR1 Capital Management LLC Acquires New Shares in PepGen, Inc. $PEPG
defenseworld.net
ADAR1 Capital Management LLC Acquires New Shares in PepGen, Inc. $PEPG

ADAR1 Capital Management LLC acquired a new position in PepGen, Inc. (NASDAQ: PEPG) in the undefined

benzinga.com
PepGen Q2 EPS $(0.26) Beats $(0.29) Estimate

PepGen (NASDAQ:PEPG) reported quarterly losses of $(0.26) per share which beat the analyst consensus

PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
gurufocus.com
PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

[url="]PepGen Inc.[/url] (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next g

PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review
gurufocus.com
PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB R

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of

benzinga.com
PepGen Receives Recommendation To Advance its Phase 2 FREEDOM2-DM1 Study Of PGN-EDODM1 In Participan

Independent Data and Safety Monitoring Board (DSMB) has recommended advancing the ongoing Phase 2 FR

PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
businesswire.com
PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

BOSTON--(BUSINESS WIRE)---- $PEPG #DM1--PepGen Reports Second Quarter 2026 Financial Results and Rec

PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review
businesswire.com
PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB R

BOSTON--(BUSINESS WIRE)---- $PEPG #DM1--PepGen to Advance PGN-EDODM1 into Highest Dose Cohort in Pha

benzinga.com
Craig-Hallum Initiates Coverage On PepGen with Buy Rating, Announces Price Target of $11

Craig-Hallum analyst Adam Vogel initiates coverage on PepGen (NASDAQ:PEPG) with a Buy rating and

benzinga.com
PepGen To Highlight Data From PGN-EDODM1 Program In Poster And Late-Breaking Oral Presentation At ID

PepGen Inc. (NASDAQ:PEPG), a clinical-stage biotechnology company advancing the next generation of o

PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Program
businesswire.com
PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting

BOSTON--(BUSINESS WIRE)--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancin

PepGen (PEPG) Loses 14.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
zacks.com
PepGen (PEPG) Loses 14.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

PepGen (PEPG) is technically in oversold territory now, so the heavy selling pressure might have exh

benzinga.com
PepGen Files For $400M Shelf Registration And $100M At-The-Market Stock Offering

https://www.sec.gov/Archives/edgar/data/1835597/000119312526228960/d132482ds3.htm

PepGen (PEPG) Upgraded to Buy: Here's What You Should Know
zacks.com
PepGen (PEPG) Upgraded to Buy: Here's What You Should Know

PepGen (PEPG) might move higher on growing optimism about its earnings prospects, which is reflected

benzinga.com
Wedbush Maintains Outperform on PepGen, Lowers Price Target to $4

Wedbush analyst Laura Chico maintains PepGen (NASDAQ:PEPG) with a Outperform and lowers the price

benzinga.com
PepGen Q1 EPS $(0.26) Beats $(0.31) Estimate

PepGen (NASDAQ:PEPG) reported quarterly losses of $(0.26) per share which beat the analyst consensus

PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
businesswire.com
PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

BOSTON--(BUSINESS WIRE)--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancin

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

NEW YORK, May 7, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors o

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

NEW YORK, April 30, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investor

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inve

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inve

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investor

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inve

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

NEW YORK, April 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

Top 3 Health Care Stocks Which Could Blast Off This Quarter
benzinga.com
Top 3 Health Care Stocks Which Could Blast Off This Quarter

Undervalued companies in health care sector with low RSI values present buying opportunity: PepGen I

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inve

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

NEW YORK, April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

NEW YORK, April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

Scholar Rock To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
benzinga.com
Scholar Rock To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on top names. For a complete view of all rating chang

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Gold Gains Over 1%; FactSet Research Raises FY2026 Outlook
benzinga.com
Gold Gains Over 1%; FactSet Research Raises FY2026 Outlook

US stocks rise on Tuesday, with NASDAQ up 2% and Dow up 1.37%. Communication services shares gain 2.

Dow Jumps 400 Points; TD Synnex Posts Upbeat Earnings
benzinga.com
Dow Jumps 400 Points; TD Synnex Posts Upbeat Earnings

US stocks higher, Dow up 0.90%, Nasdaq up 1.61%. Communication services gained 1.8%, utilities fell

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why Virgin Galactic Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Virgin Galactic Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Virgin Galactic reported Q4 revenue of $312,000, missing estimates, but beat EPS expectations. Its s

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Valneva, Venture Global And Other Big Stocks Moving Lower In Monday's Pre-Market Session
benzinga.com
Valneva, Venture Global And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Dow futures up 1000 points. Valneva stock falls in pre-market. Pfizer and Valneva announce Phase 3 r

Grocery Outlet Posts Downbeat Q4 Earnings, Joins SES AI, PepGen And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
benzinga.com
Grocery Outlet Posts Downbeat Q4 Earnings, Joins SES AI, PepGen And Other Big Stocks Moving Lower In

U.S. stock futures mixed, Grocery Outlet Holding Corp shares fall 26.3% in pre-market trading after

12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

Why Veeva Systems Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Veeva Systems Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket

Shares of Veeva Systems Inc (NYSE: VEEV) gained 11.3% in pre-market trading on upbeat Q4 results and

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

Meihua International Medical Technologies, Fly-E Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session
benzinga.com
Meihua International Medical Technologies, Fly-E Group And Other Big Stocks Moving Lower In Monday's

benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Fastenal Posts Downbeat Earnings, Joins Vince Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session
benzinga.com
Fastenal Posts Downbeat Earnings, Joins Vince Holding And Other Big Stocks Moving Lower In Monday's

benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday&#

benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday&#39

S&P 500 Falls 1%; Accenture Posts Upbeat Earnings
benzinga.com
S&P 500 Falls 1%; Accenture Posts Upbeat Earnings

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on T